1 min read

Ocular Therapeutix stock price target raised to $30 by RBC on wAMD trial outlook

Investing.com0


Ocular Therapeutix stock price target raised to $30 by RBC on wAMD trial outlook

Leave a Reply

Your email address will not be published. Required fields are marked *

Related Posts